Currently, obstructive sleep apnea (OSA) is the second most common sleep disorder and affects almost one billion adults globally,1 causing more patients to turn to CPAP therapy as part of their ...

A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...